You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Methylprednisolone acetate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for methylprednisolone acetate and what is the scope of patent protection?

Methylprednisolone acetate is the generic ingredient in six branded drugs marketed by Pharmacia And Upjohn, Pfizer, Bel Mar, Amneal, Epic Pharma Llc, Eugia Pharma, Hong Kong, Par Sterile Products, Sagent Pharms Inc, Sandoz, Slayback Pharma Llc, Teva Pharms Usa, and Watson Labs, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for methylprednisolone acetate. Eleven suppliers are listed for this compound.

Drug Prices for methylprednisolone acetate

See drug prices for methylprednisolone acetate

Drug Sales Revenue Trends for methylprednisolone acetate

See drug sales revenues for methylprednisolone acetate

Recent Clinical Trials for methylprednisolone acetate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Menoufia UniversityN/A
Centre hospitalier de l'Université de Montréal (CHUM)Phase 4
Department of Anesthesiology Faculty Development FundPhase 2

See all methylprednisolone acetate clinical trials

Pharmacology for methylprednisolone acetate

US Patents and Regulatory Information for methylprednisolone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 085597-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Slayback Pharma Llc METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 214870-002 May 10, 2023 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Teva Pharms Usa METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 040620-001 Oct 27, 2006 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sagent Pharms Inc METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 201835-002 Jun 27, 2018 AB RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sandoz METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 040794-001 Mar 5, 2009 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bel Mar M-PREDROL methylprednisolone acetate INJECTABLE;INJECTION 087135-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.